Onconaut Therapeutics Inc.
PrivateLast Round
Grant
Nov 20, 2025
Total Funding Raised
$2.75M
Company Overview
Onconaut Therapeutics Inc. is a biopharmaceutical company developing small molecule therapeutics intended for the treatment of various aggressive and drug-resistant cancers by targeting the CHD1L oncogene.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Onconaut Therapeutics Inc. Comps
Public and private peers based on sector, stage, and business model.
Onconaut Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 20, 2025 | ||||
| Grant | Aug 28, 2025 |
Onconaut Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Colorado Office of Economic Development and International Trade | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
$247K grant from Colorado Office of Economic Development and International Trade.
- Aug 28, 2025
Received $3M from National Cancer Institute and NIH RADx.
Onconaut Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Onconaut Therapeutics Inc.'s valuation, stock price, and market status.
